Dr. Alan C. Hartford, MD, PhD

Dr. Hartford practices at Umass Memorial Medical Group Inc in Worcester, Massachusetts.

Dr. Hartford's NPI, 1912017732, was assigned on August 30, 2006. Dr. Hartford graduated from Harvard Medical School in 1992. Dr. Hartford holds Massachusetts license 150344.

Dr. Hartford's primary practice is Umass Memorial Medical Group Inc, at 55 Lake N Ave, Worcester, MA 01605 in Worcester County. The practice phone is (508) 334-1000.

Dr. Hartford's primary practice is Umass Memorial Medical Group Inc in Worcester, Massachusetts. Dr. Hartford is also affiliated with UMass Memorial Medical Center - University Campus. The medical group on file is UMass Memorial Medical Group. Dmand AI also links Dr. Hartford to 2 more hospitals, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hartford practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Hartford's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Hartford is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Hartford's licenses on file in 3 states: Massachusetts, New Hampshire and Vermont.

Dmand AI lists bladder cancer radiation, bone cancer radiation, brain cancer radiation, brain tumor radiation and prostate cancer radiation among the conditions Dr. Hartford treats.

CMS data shows 536 Medicare services from Dr. Hartford across 9 procedure codes in 2024, for 131 Medicare patients. Medicare paid $37,813 for them.

CMS counts 131 Medicare patients who saw Dr. Hartford in 2024. The largest group is 75 to 84, with 61 patients. 75% of them have cancer, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hartford's median patient age at 75, with 30% women.

In 2024, Dr. Hartford wrote 40 Medicare Part D claims for 19 patients. 83% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $272 in total drug cost. In 2023, CMS named 216 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Hartford for performance year 2024, reported through an alternative payment model (APM). Dr. Hartford accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 52 papers to Dr. Hartford, published from 2004 to 2025. 2018 was the busiest year, with 4. The most frequent topics are Prostatic Neoplasms, Androgen Antagonists and Brain Neoplasms. Dr. Hartford has published most often in Int J Radiat Oncol Biol Phys. Dr. Hartford's most frequent co-authors are Seth Allen Rosenthal, MD, Howard M. Sandler, MD and Jeff Michael Michalski, MD.

Dmand AI links Dr. Hartford to 23 clinical trials, 14 of them phase 3 studies. 16 are still active or recruiting. Conditions studied include Prostatic Neoplasms, Prostatic Diseases and Tongue Neoplasms. NRG Oncology sponsors the most, 9.

CMS Open Payments shows 3 general payments to Dr. Hartford from 3 drug and device companies from 2020 to 2024. Food and beverage make up the largest share, 100% of the total. Elekta, Inc. paid the most, $125.

Dmand AI lists 3 awards for Dr. Hartford, most recently America's Top Doctors in 2014.

Dr. Hartford graduated from Harvard Medical School in 1992.

Dr. Hartford is in network with 18 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.